Document |
Document Title |
WO/1996/005176A1 |
A fused pyridazine compound represented by general formula (I) and having the inhibitory effect against cyclic GMP-phosphodiesterase (cGMP-PDE), and a pharmacologically acceptable salt thereof. These compounds are useful as preventives a...
|
WO/1996/004256A1 |
A process for preparing an antifungal azole compound of formula (I) by reacting an epoxide with hydrazine to form a hydrazino compound which is subsequently reacted with an iminoether. The amidrazone product is subsequently reacted with ...
|
WO/1996/004278A1 |
An oxazole derivative represented by general formula (I) and a salt thereof, excellent in herbicidal activity, and useful as a herbicide, wherein A represents a nitrogen atom or an R3-substituted carbon atom; B represents a nitrogen atom...
|
WO/1996/004274A1 |
A class of substituted azetidine, pyrrolidine and piperidine derivatives are selective agonists of 5-HT1-like receptors, being potent agonists of the human 5-HT1D'alpha' receptor subtype whilst possessing at least a 10-fold selective aff...
|
WO/1996/004242A1 |
Arylthiol and dithiobisarylamide antibacterial and antiviral agents have general formula (I) where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N, R1 and R2 are substituent groups, X is (...
|
WO/1996/004287A1 |
Compounds of general formula (I) for drugs having therapeutic use in the treatment of anxiety, psychosis, epilepsy, convulsion, motor control disorders, amnesia, cerebrovascular diseases and senile dementia.
|
WO/1996/004269A1 |
Compounds of formula (I), or a salt or prodrug thereof, wherein Z represents an optionally substituted five-membered heteroaromatic ring selected from furan, thiophene, pyrrole, oxazole, thiazole, isoxazole, isothiazole, imidazole, pyraz...
|
WO/1996/004257A1 |
A crystalline form of the antifungal agent (+)-2-(2,4-difluorophenyl)-1-[3-[(E)-4-(2,2,3,3-tetrafluorop
ropoxy)-styryl]-1H-1,2,4-triazol-1-yl]-3- (1H-1,2,4-triazol-1-yl)propan-2-ol (code D0870) is described. Furthermore processes for the...
|
WO/1996/004231A1 |
A novel amine derivative represented by general formula (I) and a salt thereof, each being useful as an antiarrhythmic, wherein, for example, A represents -(CH2)-O-, -(CH2)2-O- or -(CH2)2-NH-; B represents -(CH2)2-; R1 represents hydroge...
|
WO/1996/003389A1 |
The invention concerns novel azolylmethylcycloalkanol derivatives, their preparation and their use for protecting technical materials and plants against microbial infection.
|
WO/1996/003390A1 |
The invention concerns novel azolylmethylcyclopentanol derivatives, their preparation and use for protecting technical materials and plants against microbial infection.
|
WO/1996/002532A1 |
The present invention concerns 7-substituted 1-[4-(1H-1,2,4-triazol-1-yl-methyl)phenyl] substituted quinolone carboxylic acids of general formula (I), in which the substituents have the meanings given in the description. The invention fu...
|
WO/1996/002539A1 |
Novel substituted triazolyl methyl phenyl naphthyridones of general formula (I) in which A is hydrogen or methyl, R1 is phenyl, naphthyl, pyridyl, pyrimidyl or pyrazinyl, which may be substituted triply identically or differently by nitr...
|
WO/1996/002505A1 |
Compounds having the formula (I), in which the substituents and symbols have the meanings given in the description, are useful for controlling helicobacter bacteria.
|
WO/1996/002533A1 |
The invention pertains to 6- and 6,8-substituted 1-[4-(1H-1,2,4-triazol-1-yl methyl) phenyl] quinolone carboxylic acids of general formula (I), in which A is hydrogen or methyl, R1 is phenyl, naphthyl, pyridyl, pyrimidyl or pyrazinyl, op...
|
WO/1996/002664A1 |
A process for the asymmetric synthesis of a compound represented by general formula (II-R) easily at a low cost by using a lipase, and a process for producing a compound to be utilized in the above synthesis.
|
WO/1996/002498A1 |
Carbamic acid vinyl ester compounds are produced by the reaction of corresponding secondary amines with carbon dioxides and acetylenically unsaturated compounds in the presence of a compound of a metal of the platinum group, especially a...
|
WO/1996/002508A1 |
The present invention provides novel cyclic amide derivatives having activity for protecting against the ultraviolet rays, activity for scavenging active oxygen species and activity for inhibiting the formation of lipid peroxides, which ...
|
WO/1996/002564A1 |
There is disclosed a process for the preparation of compounds having ACE inhibitory action of formula (1) wherein R has the meanings as in claim 1, wherein the stereospecific amino acid N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine i...
|
WO/1996/002511A1 |
N1 diverse 6-fluorine-8-difluoromethoxy substituted quinolone carboxylic acids of the general formula (I) in which A is hydrogen or methyl, R1 is phenyl, pyridyl, pyrimidyl or pyrazinyl, which may be substituted up to triply, equally or ...
|
WO/1996/002499A1 |
The present invention provides novel difluorostatone derivatives of general formula (I), which are useful as antiviral agents. More specifically, these novel compounds are useful as inhibitors of retroviral proteases required for replica...
|
WO/1996/002003A1 |
Novel alkoxythiocarbonylimidazoles provide new reagents for the N-terminal sequencing of small polypeptides samples. These reagents form an alkoxy thiourea derivative which is cleaved with acid to remove the N-terminal amino acid as a st...
|
WO/1996/001817A1 |
There are provided compounds of formula (I), wherein D represents a five membered heterocyclic aromatic ring containing 1 to 4 heteroatoms selected from O, N or S, optionally substituted at a carbon atom by halogen, trifluoromethyl, alky...
|
WO/1996/001823A1 |
Described is a process for preparing chiral compounds of formula (II), wherein X1 and X2 are independently F or Cl, and Y is Cl, Br or I, comprising reacting a triol of formula (VIII), wherein X1 and X2 are as defined above, with acetone...
|
WO/1996/001814A1 |
Compounds of formula (I), in which R1 is a substituent bonded via a carbon atom, R4 is a substituent, R2 and R3 are hydrogen or substituents and X is O, S, SO or SO2, are suitable as herbicides.
|
WO/1996/000738A1 |
Novel antagonists of endothelin containing an N-terminal fragment (I) are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute an...
|
WO/1996/000214A1 |
Compounds of formula (I) wherein R, R1, R2 and Ar are as defined in the specification, have valuable pharmaceutical properties and are effective especially as matrix metalloproteinase inhibitors, for example for the treatment of arthriti...
|
WO/1996/000219A1 |
Compounds of formula (I), wherein R1 is C1-C7 haloalkyl; X is oxygen or sulfur; and salts of compounds of formula (I) that contain a carboxy or sulfonamide group, and stereoisomers of the compounds of formula (I), are suitable as active ...
|
WO/1996/000378A1 |
Novel compounds are provided which are useful as photocleavable linking groups in solid phase synthesis. Compositions incorporatinf these linking groups and methods for their use are also described.
|
WO/1996/000223A1 |
A process for producing a compound of formula (2) of value as anti-inflammatory agents, which comprises reacting a compound of formula (3) or a salt thereof with 4-amino-1,2,4-triazole to give a compound of formula (1) or a salt thereof ...
|
WO/1995/035308A1 |
The present invention relates to novel classes of compounds which are inhibitors of interleukin-1'beta' converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This i...
|
WO/1995/035275A1 |
Compounds of general formula (II) wherein X is a hydroxamic or carboxylic acid group, Y is carbonyl or sulphonyl and R1 and R2 are as defined in the claims, are matrix metalloproteinase inhibitors.
|
WO/1995/035276A1 |
Compounds of general formula (II), wherein X is a hydroxamic or carboxylic acid group, Y is sulphonyl and R1 and R2 as defined in the claims are matrix metalloproteinase inhibitors.
|
WO/1995/035281A1 |
Compounds of general formula (1) are described, wherein = W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m- [where m is zero or an integer of value 1 or 2], or -N(Rb)- [where Rb is a hydrogen a...
|
WO/1995/035286A1 |
Oligopeptide analogs containing sulfonamide, urea or carbamate linkages in the backbone are described. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AID...
|
WO/1995/035283A1 |
Compounds of general formula (1) are described, formula wherein =W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m- [where m is zero or an integer of value 1 or 2], or -N(Rb)- [where Rb is a hyd...
|
WO/1995/034526A1 |
The invention concerns a method of preparing 'alpha'-methoxyiminocarboxylic acid methylamides of formula (I) (X = nitro, trifluoromethyl, halogen, alkyl or alkoxy; n = 0, 1, 2, 3 or 4; Y = an organic carbon group) by the Pinner reaction ...
|
WO/1995/034542A1 |
A triazole compound represented by general formula (I) or a physiologically acceptable salt or hydrate thereof, and an antifungal agent containing the same as the active ingredient, wherein R1 represents hydrogen or methyl; R2 represents...
|
WO/1995/034540A1 |
A benzoheterocyclic derivative of formula (1) and pharmaceutically acceptable salts thereof, which show excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as a vasopress...
|
WO/1995/034311A1 |
Novel piperazine compounds promote the release of growth hormone in humans and animals. This property may be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, t...
|
WO/1995/034547A1 |
The invention provides certain 5 and/or 8 substituted benzopyran, pyranopyridine or tetrahydroquinaline compounds having a C-4 amide substituent and processes for making them. The compounds described are useful in treating and/or prevent...
|
WO/1995/033710A1 |
Disclosed are carbamoyl carboxylic acid hydrazides (I) and their salts, wherein: R1 is optionally substitued alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, aryl or heteroaryl or an optionally substituted non-aromatic carbo- or hetero...
|
WO/1995/032710A1 |
Compounds of the following general structure: X-Y-Z-Aryl-A-B, for example (I), which inhibit osteoclast-mediated bone resorption.
|
WO/1995/032950A1 |
The invention concerns compounds of formula (I) in which R1 is H, a substituted or unsubstituted hydrocarbon group or a substituted or unsubstituted heterocyclic group; R2 is H, C1-C6 alkyl or C1-C6 alkoxy; R3 is halogen, C1-C6 alkyl, C1...
|
WO/1995/032951A1 |
Salts of formula (I), wherein n is 0, 1, 2 or 3; R is a halogen, alkyl or alkoxy, independently of one another when n is greater than 1; R1 is a substituted or unsubstituted hydrocarbon radical or a substituted or unsubstituted heterocyc...
|
WO/1995/032944A1 |
Compounds of general formula (I) wherein X is a -CO2H, -N(OH)CHO or -CONHOH group; R1 is hydrogen; (C1-C6)alkyl; (C2-C6)alkenyl; phenyl; substituted phenyl; phenyl(C1-C6)alkyl; substituted phenyl(C1-C6)alkyl; heterocyclyl; substituted he...
|
WO/1995/032197A1 |
A new process is described for the synthesis of the triazolyl tryptamine ('alpha') and related compounds. The process involves a palladium-catalyzed ring closure between a substituted ortho-iodoaniline and a protected 1-alkynol. The proc...
|
WO/1995/032452A1 |
The subject invention relates to novel dihydrazide compounds of the general formula: B-(A+)-C (G-) where B and C are the same or different and have general structure (I). A+ is an activity regulating group, and G- is a negatively charged...
|
WO/1995/032185A1 |
HIV protease inhibitors of formula (1), in which Q1 to Q8, E, and Y are as defined in Claim 1, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV viru...
|
WO/1995/032196A1 |
Compounds of formula (I), or a salt or prodrug thereof, wherein Z represents an optionally substituted five-membered heteroaromatic ring selected from furan, thiophene, pyrrole, oxazole, thiazole, isoxazole, isothiazole, imidazole, pyraz...
|